Longitudinally quantitative 2-deoxy-2-[18F]fluoro-D-glucose micro positron emission tomography imaging for efficacy of new anticancer drugs: a case study with bortezomib in prostate cancer murine model. (Q53525226)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Longitudinally quantitative 2-deoxy-2-[18F]fluoro-D-glucose micro positron emission tomography imaging for efficacy of new anticancer drugs: a case study with bortezomib in prostate cancer murine model.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/16897318

Longitudinally quantitative 2-deoxy-2-[18F]fluoro-D-glucose micro positron emission tomography imaging for efficacy of new anticancer drugs: a case study with bortezomib in prostate cancer murine model. (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/16897318

positron emission tomography

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Yumin Zhang

1

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/16897318

Melissa Saylor

2

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/16897318

Shenhua Wen

3

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/16897318

Matthew D Silva

4

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/16897318

Mark Rolfe

5

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/16897318

Joseph Bolen

6

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/16897318

Craig Muir

7

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/16897318

Corinne Reimer

8

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/16897318

Sudeep Chandra

9

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/16897318

publication date

1 September 2006

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/16897318

Molecular Imaging and Biology

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/16897318

8

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/16897318

5

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/16897318

300-308

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/16897318

Performance evaluation of the microPET R4 PET scanner for rodents.

1 reference

https://api.crossref.org/works/10.1007%2FS11307-006-0052-5

21 January 2018

[(18)F]FDG PET monitoring of tumour response to chemotherapy: does [(18)F]FDG uptake correlate with the viable tumour cell fraction?

1 reference

https://api.crossref.org/works/10.1007%2FS11307-006-0052-5

21 January 2018

CT evaluation of the response of gastrointestinal stromal tumors after imatinib mesylate treatment: a quantitative analysis correlated with FDG PET findings

1 reference

https://api.crossref.org/works/10.1007%2FS11307-006-0052-5

21 January 2018

MicroPET assessment of androgenic control of glucose and acetate uptake in the rat prostate and a prostate cancer tumor model

1 reference

https://pubmed.ncbi.nlm.nih.gov/16897318

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Targeted therapies for cancer 2004.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16897318

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Understanding the tumor metabolic phenotype in the genomic era.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16897318

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://pubmed.ncbi.nlm.nih.gov/16897318

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Why do cancers have high aerobic glycolysis?

1 reference

https://pubmed.ncbi.nlm.nih.gov/16897318

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anatomy of SUV. Standardized uptake value

1 reference

https://pubmed.ncbi.nlm.nih.gov/16897318

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prostate-specific membrane antigen-targeted monoclonal antibody-chemotherapeutic conjugate designed for the treatment of prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16897318

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Can positron emission tomography (PET) be used to detect subclinical response to cancer therapy? The EC PET Oncology Concerted Action and the EORTC PET Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/16897318

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation of glucose consumption and tumor cell density in astrocytomas. A stereotactic PET study

1 reference

https://pubmed.ncbi.nlm.nih.gov/16897318

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proteasome inhibition: a new strategy in cancer treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/16897318

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changes in 18F-FDG uptake measured by PET as a pharmacodynamic end-point in anticancer therapy. How far have we got?

1 reference

https://pubmed.ncbi.nlm.nih.gov/16897318

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential effects of the proteasome inhibitor bortezomib on apoptosis and angiogenesis in human prostate tumor xenografts

1 reference

https://pubmed.ncbi.nlm.nih.gov/16897318

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Studies with CWR22 xenografts in nude mice suggest that ZD1839 may have a role in the treatment of both androgen-dependent and androgen-independent human prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16897318

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

From tumor biology to clinical Pet: a review of positron emission tomography (PET) in oncology

1 reference

https://pubmed.ncbi.nlm.nih.gov/16897318

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The proteasome inhibitor bortezomib stabilizes a novel active form of p53 in human LNCaP-Pro5 prostate cancer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/16897318

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of 18F-FDG PET in staging and early prediction of response to therapy of recurrent gastrointestinal stromal tumors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16897318

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterizing tumors using metabolic imaging: PET imaging of cellular proliferation and steroid receptors

1 reference

https://pubmed.ncbi.nlm.nih.gov/16897318

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Accelerated image reconstruction using ordered subsets of projection data

1 reference

https://pubmed.ncbi.nlm.nih.gov/16897318

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A tabulated summary of the FDG PET literature.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16897318

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of PET, CT, and dual-modality PET/CT imaging for monitoring of imatinib (STI571) therapy in patients with gastrointestinal stromal tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/16897318

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Ki-67 index and survival in non-small cell lung cancer: a review and relevance to positron emission tomography

1 reference

https://pubmed.ncbi.nlm.nih.gov/16897318

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oncogenic alterations of metabolism

1 reference

https://pubmed.ncbi.nlm.nih.gov/16897318

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proteasome inhibitors: a novel class of potent and effective antitumor agents.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16897318

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative assessment of tumor metabolism using FDG-PET imaging

1 reference

https://pubmed.ncbi.nlm.nih.gov/16897318

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monitoring antiproliferative responses to kinase inhibitor therapy in mice with 3'-deoxy-3'-18F-fluorothymidine PET.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16897318

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11307-006-0052-5

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/16897318

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/16897318

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53525226&oldid=2212195681"